Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections (Q44417870)

2 December 2017

Voriconazole treatment for less-common, emerging, or refractory fungal infections (English)

1 reference

2 December 2017

Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections (English)

1 reference

27 December 2023

1 reference

9

Irja Lutsar

1 reference

2 December 2017

1

John R Perfect

1 reference

2 December 2017

10

Ana Espinel-Ingroff

1 reference

2 December 2017

3

Thomas J Walsh

1 reference

2 December 2017

2

Kieren A Marr

1 reference

2 December 2017

Bertrand DuPont

5

1 reference

2 December 2017

Juliàn de la Torre-Cisneros

6

1 reference

2 December 2017

Gudrun Just-Nübling

7

1 reference

2 December 2017

Elizabeth Johnson

11

1 reference

2 December 2017

Richard N. Greenberg

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12715306

27 December 2023

Haran T. Schlamm

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12715306

27 December 2023

language of work or name

English

0 references

publication date

22 April 2003

1 reference

Clinical Infectious Diseases

2 December 2017

1 reference

2 December 2017

36

1 reference

2 December 2017

9

1 reference

2 December 2017

1122-1131

1 reference

Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis

2 December 2017

1 reference

The search for new triazole antifungal agents

21 January 2018

1 reference

Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children

21 January 2018

1 reference

A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients

21 January 2018

1 reference

Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever

21 January 2018

1 reference

Fungal infections in patients with neutropenia: challenges in prophylaxis and treatment

21 January 2018

1 reference

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

21 January 2018

1 reference

Successful treatment of cerebral aspergillosis with a novel triazole (voriconazole) in a patient with acute leukaemia.

21 January 2018

1 reference

Successful treatment of ocular invasive mould infection (fusariosis) with the new antifungal agent voriconazole

21 January 2018

1 reference

Successful outcome of Scedosporium apiospermum disseminated infection treated with voriconazole in a patient receiving corticosteroid therapy

21 January 2018

1 reference

Pseudallescheria boydii brain abscess successfully treated with voriconazole and surgical drainage: case report and literature review of central nervous system pseudallescheriasis

21 January 2018

1 reference

In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: review of the literature

21 January 2018

1 reference

In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi

21 January 2018

1 reference

Aspergillosis case-fatality rate: systematic review of the literature

21 January 2018

1 reference

Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group

21 January 2018

1 reference

The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis.

21 January 2018

1 reference

Efficacy and safety of amphotericin B lipid complex injection (ABLC) in solid-organ transplant recipients with invasive fungal infections.

21 January 2018

1 reference

Protists as opportunistic pathogens: public health impact in the 1990s and beyond

21 January 2018

1 reference

Epidemiology of fungal infections in solid organ transplant patients

21 January 2018

1 reference

Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients

21 January 2018

1 reference

The safety of voriconazole

21 January 2018

1 reference

Antigen detection in the diagnosis and management of a patient with probable cerebral aspergillosis treated with voriconazole

21 January 2018

10

1 reference

Microgranulomatous aspergillosis in a patient with chronic granulomatous disease: cure with voriconazole

27 December 2023

13

1 reference

Successful treatment with voriconazole of invasive aspergillosis in chronic granulomatous disease

27 December 2023

14

1 reference

Use of voriconazole in treatment of Scedosporium apiospermum infection: case report

27 December 2023

19

1 reference

Cutaneous infection caused by Paecilomyces lilacinus in a renal transplant patient: treatment with voriconazole

27 December 2023

20

1 reference

Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi

27 December 2023

25

1 reference

Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases.

27 December 2023

27

1 reference

Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases.

27 December 2023

29

1 reference

A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute

27 December 2023

36

1 reference

Breakthrough fungemia appearing during empiric therapy with amphotericin B

27 December 2023

37

1 reference

27 December 2023

Identifiers

DOI

10.1086/374557

1 reference

2 December 2017

1 reference